RELMADA THERAPEUTICS INC
RLMD·75955J402·US·Common Stock·Healthcare - Biotechnology-13D/G
RLMD (RELMADA THERAPEUTICS INC) is held by 67 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($51.4M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($33M), VANGUARD CAPITAL MANAGEMENT LLC ($30.9M). Net institutional sentiment: Bullish.
67
Holders
(1 Elite)
$303.5M
Total Value
68% (74)
Consensus
50 buying - 24 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 21, 2026 · Insiders Dec 16, 2025 · Activists Aug 14, 2026 · Congress none
ActivistSMSquadron Master Fund LP7.0%Aug 14, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 80
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer